Valuation Kamada Ltd.

Stocks

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 15:24:39 13/07/2026 BST			5-day change	1st Jan Change
2,158.00 ^ILa	+1.22%		-4.09%	-4.51%

07-13	Kamada Ltd. Highlights CYTOGAM Study Results Presented at The 2026 ISHLT Annual Meeting	CI
06-01	Kamada Announces FDA Approval of Its New In-House Rabies Virus Neutralization Testing Laboratory	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	920.4	615	1,280	1,271	1,304	1,245	-	-
Change	-	-33.18%	108.12%	-0.69%	2.55%	-4.51%	-	-
Enterprise Value (EV)	920.4	615	1,280	1,271	1,304	1,245	1,245	1,245
Change	-	-33.18%	108.12%	-0.69%	2.55%	-4.51%	0%	0%
P/E	-	-	-	-	-	-	-	-
PBR	-	-	-	-	-	-	-	-
PEG	-	-	-	-	-	-	-	-
Capitalization / Revenue	2.7x	1.31x	2.51x	2.17x	2.35x	2.13x	1.94x	1.74x
EV / Revenue	0x	0x	0x	0x	0x	2.13x	1.94x	1.74x
EV / EBITDA	-	-	0x	0x	0x	8.28x	6.85x	6.58x
EV / EBIT	-0x	0x	0x	0x	0x	12.4x	9.95x	8.22x
EV / FCF	-0x	-	-0x	0x	0x	16.5x	11.8x	9.34x
FCF Yield	-4.52%	-	-0.43%	10.5%	3.73%	6.07%	8.46%	10.7%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-	-	-	-	-	-	-	-
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	340.3	469.1	510.9	586.9	555.7	584.7	641.9	716.6
EBITDA ¹	-	-	86.36	124.5	129.3	150.3	181.7	189.2
EBIT ¹	-2.286	16.44	36.08	73.11	80.79	100	125.1	151.5
Net income ¹	-7.323	-8.417	29.7	52.73	62.2	72.01	103.6	127.2
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	20.55	13.72	22.27	22.11	22.60	21.58	21.58	21.58
Nbr of stocks (in thousands)	44,786	44,826	57,476	57,492	57,682	57,686	-	-
Announcement Date	15/03/22	15/03/23	06/03/24	05/03/25	11/03/26	-	-	-

¹ILS in Million²

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
KAMADA LTD.	-	-	-	-	409M
REGENERON PHARMACEUTICALS, INC.	17.35x	3.77x	10.12x	0.59%	67.61B
UCB	25.62x	5.26x	15.43x	0.62%	51.6B
SAMSUNG BIOLOGICS CO.,LTD.	34.5x	11.72x	22.4x	-.--%	43B
CSL LIMITED	-46.01x	3.23x	9.56x	3.34%	40.94B
BIOGEN INC.	30.35x	3.47x	10.97x	-.--%	29.4B
MODERNA, INC.	-7.88x	11.31x	-6.94x	-.--%	27.09B
INCYTE CORPORATION	37.89x	3.25x	9.81x	-.--%	23.32B
INNOVENT BIOLOGICS, INC.	62.11x	6.31x	43.4x	-.--%	19.92B
SWEDISH ORPHAN BIOVITRUM AB	26.16x	5.4x	14.45x	-.--%	16.91B
Average	20.01x	5.97x	14.35x	0.5%	32.02B
Weighted average by Cap.	16.69x	5.83x	13.47x	0.65%